CLINICAL_TRIALS
trial_result
· 2014-04-15
Clinical Trial Update: A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies [Phase 2]
Summary
A Phase 2 companion study evaluating patients previously enrolled in ipilimumab trials for melanoma has completed, with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2014-04-15